Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Jaideep Behari"'
Autor:
Mengying Xia, Mahboubeh Varmazyad, Iris Pla-Palacín, Dillon C. Gavlock, Richard DeBiasio, Gregory LaRocca, Celeste Reese, Rodrigo M. Florentino, Lanuza A. P. Faccioli, Jacquelyn A. Brown, Lawrence A. Vernetti, Mark Schurdak, Andrew M. Stern, Albert Gough, Jaideep Behari, Alejandro Soto-Gutierrez, D. Lansing Taylor, Mark T. Miedel
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 12 (2024)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a worldwide health epidemic with a global occurrence of approximately 30%. The pathogenesis of MASLD is a complex, multisystem disorder driven by multiple factors, including genetics
Externí odkaz:
https://doaj.org/article/ee7744aae33d4960a923808275c298d0
Autor:
Maria Hernandez-Tejero, Samhita Ravi, Jaideep Behari, Gavin E. Arteel, Juan Pablo Arab, Ramon Bataller
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 1, Pp 96-100 (2024)
Externí odkaz:
https://doaj.org/article/46d5c1c4b1c14327beda3828d4e37498
Autor:
Zehra N. Kocas-Kilicarslan, Zeliha Cetin, Lanuza A.P. Faccioli, Takashi Motomura, Sriram Amirneni, Ricardo Diaz-Aragon, Rodrigo M. Florentino, Yiyue Sun, Iris Pla-Palacin, Mengying Xia, Mark T. Miedel, Takeshi Kurihara, Zhiping Hu, Alina Ostrowska, Zi Wang, Robert Constantine, Albert Li, D. Lansing Taylor, Jaideep Behari, Alejandro Soto-Gutierrez, Edgar N. Tafaleng
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 1, Pp 67-77 (2024)
Background and Aims: Chronic liver injury that results in cirrhosis and end-stage liver disease (ESLD) causes more than 1 million deaths annually worldwide. Although the impact of genetic factors on the severity of metabolic dysfunction-associated st
Externí odkaz:
https://doaj.org/article/a352c00a654e49048cd6eb2ec5a1d2e4
Autor:
Claire E. Thomas, Yi‐Chuan Yu, Hung N. Luu, Renwei Wang, Pedram Paragomi, Jaideep Behari, Jian‐Min Yuan
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 3589-3600 (2023)
Abstract Background Blood neutrophil to lymphocyte ratio (NLR) or lymphocyte count may be important markers for immune function. Previous work has shown higher NLR was associated with higher risk of hepatitis B‐related hepatocellular carcinoma (HCC
Externí odkaz:
https://doaj.org/article/e5aec39a20f34e58b05e61117deaf54f
Autor:
Lanuza A. P. Faccioli, Zeliha Cetin, Zehra N. Kocas-Kilicarslan, Kimberly Ortiz, Yiyue Sun, Zhiping Hu, Takeshi Kurihara, Edgar N. Tafaleng, Rodrigo M. Florentino, Zi Wang, Mengying Xia, Mark T. Miedel, D. Lansing Taylor, Jaideep Behari, Alina Ostrowska, Robert Constantine, Albert Li, Alejandro Soto-Gutierrez
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 17, p 13406 (2023)
Metabolic-dysfunction-associated steatotic liver disease (MASLD), which affects 30 million people in the US and is anticipated to reach over 100 million by 2030, places a significant financial strain on the healthcare system. There is presently no FD
Externí odkaz:
https://doaj.org/article/8471cbb831af478fb2c14395e536252e
Autor:
Jaideep Behari
Publikováno v:
Gastro Hep Advances, Vol 2, Iss 1, Pp 158-159 (2023)
Externí odkaz:
https://doaj.org/article/c945a206e5bf42ba8283385ee0b06d40
Autor:
Jaideep Behari, Lisa Graham, Renwei Wang, Claudiu Schirda, Amir A. Borhani, Barbara A. Methé, Kelvin Li, Alison Morris, Hung N. Luu, Sabrina Palmieri, Jian‐Min Yuan
Publikováno v:
Obesity Science & Practice, Vol 7, Iss 2, Pp 217-225 (2021)
Abstract Background Weight loss is recommended as the primary treatment for nonalcoholic fatty liver disease (NAFLD). However, the magnitude and velocity of hepatic steatosis resolution with weight loss is unclear, making it difficult to counsel pati
Externí odkaz:
https://doaj.org/article/bdffde6c7f8d4de4a0acd1ab44e613ba
Publikováno v:
Hepatology Communications, Vol 4, Iss 10, Pp 1419-1429 (2020)
Nonalcoholic fatty liver disease (NAFLD) is closely associated with obesity. The prevalence of extreme obesity, defined as body mass index (BMI) of 50 kg/m2 or higher, is rising more rapidly than overall obesity. We aimed to compare the clinical outc
Externí odkaz:
https://doaj.org/article/4eafaf277cd44787b0ef8615ed06ac4c
Autor:
Michele Molinari, MD, MSc, Christof Kaltenmeier, MD, Patrick-Bou Samra, MD, Hao Liu, MD, PhD, Charles Wessel, MLS, Mary Lou Klem, MLS, Stalin Dharmayan, MD, Bishoy Emmanuel, MD, Hasan Al Harakeh, MD, Samer Tohme, MD, David Geller, MD, Amit Tevar, MD, Christopher B. Hughes, MD, Abhinav Humar, MD, Ramon Bataller, MD, PhD, Jaideep Behari, MD
Publikováno v:
Annals of Surgery Open, Vol 2, Iss 2, p e065 (2021)
Objective:. To systematically review and compare the overall (OS) and disease-free (DFS) survival after hepatic resections for hepatocellular carcinoma (HCC) of patients with nonalcoholic fatty liver disease (NAFLD) versus other risk factors. Backgro
Externí odkaz:
https://doaj.org/article/38a2c26881c04204a7873bd24306c9c2
Publikováno v:
Hepatology Communications, Vol 3, Iss 10, Pp 1347-1355 (2019)
Weight loss is the primary intervention for nonalcoholic fatty liver disease (NAFLD). A decrease in resting metabolic rate (RMR) out of proportion to the degree of weight loss may promote weight regain. We aimed to determine the impact of hepatic ste
Externí odkaz:
https://doaj.org/article/244a70a7fff74864ab926f6cbc969755